Angeles Wealth Management LLC Purchases New Position in Cardinal Health, Inc. (NYSE:CAH)

Angeles Wealth Management LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,736 shares of the company’s stock, valued at approximately $205,000.

Several other large investors have also added to or reduced their stakes in the business. MWA Asset Management lifted its position in Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after acquiring an additional 95 shares in the last quarter. Paragon Capital Management Inc. boosted its stake in shares of Cardinal Health by 0.7% in the 3rd quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company’s stock worth $1,642,000 after buying an additional 99 shares during the last quarter. Huntington National Bank boosted its stake in shares of Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after buying an additional 100 shares during the last quarter. Frazier Financial Advisors LLC boosted its stake in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares during the last quarter. Finally, Raleigh Capital Management Inc. boosted its stake in shares of Cardinal Health by 29.6% in the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock worth $55,000 after buying an additional 106 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.1 %

NYSE:CAH opened at $127.30 on Tuesday. The stock has a market cap of $30.75 billion, a P/E ratio of 23.75, a PEG ratio of 1.49 and a beta of 0.63. The business’s 50-day moving average price is $122.55 and its two-hundred day moving average price is $115.62. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

CAH has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research note on Tuesday, January 7th. Finally, Morgan Stanley upped their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.